Skip to main content
TipRanks
Go Ultimate75% OFF

MindMaze Therapeutics Holding SA (V6M) Q2 2024 Earnings Report

1 Followers

DE:V6M Q2 2024 EPS Results

Actual EPS
-EUR 0.38
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 5.40

DE:V6M Q2 2024 Revenue Results

Actual Revenue
EUR 5.91M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+84.62%

Earnings Announcement Details

Quarter
Q2 2024
Date
08/30/2024
Time
Before Open
Conference Call
Friday, August 30, 2024

Q2 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:V6M Earnings History

DE:V6M earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Aug 27, 20262026 (Q2)―-0.05-0.3887.39% (+0.33)
Apr 09, 20262025 (Q4)―--1.06―
Aug 29, 20252025 (Q2)―-0.38-0.381.65% (+0.01)
Apr 10, 20252024 (Q4)―-1.06-3.5269.86% (+2.46)
Aug 30, 20242024 (Q2)―-0.38-5.492.88% (+5.02)
Mar 29, 20242023 (Q4)―-――
Sep 15, 20232023 (Q2)―-5.40-2.7-99.76% (-2.70)
Mar 31, 20232022 (Q4)―-2.39-2.23-7.22% (-0.16)
Sep 15, 20222022 (Q2)―-2.70-1.86-45.00% (-0.84)
Mar 31, 20222021 (Q4)―-2.23-325.71% (+0.77)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed